---

ACUTE SUPPURATIVE OTITIS MEDIA (ASOM)

A Comprehensive 50-Mark Answer

---

DEFINITION

---

ETIOPATHOGENESIS

1. Predisposing Factors

• Age: Most common in children 6 months – 6 years (immature immune system, shorter/horizontal Eustachian tube)
• Male sex (slightly more common)
• Cleft palate, Down syndrome, ciliary dyskinesia
• Immunodeficiency (IgA, IgG subclass deficiency)
• Adenoid hypertrophy (mechanical obstruction of Eustachian tube)
• Craniofacial abnormalities

• Daycare attendance (increased exposure to respiratory pathogens)
• Bottle-feeding in supine position (milk reflux into ET)
• Passive smoking
• Overcrowding, low socioeconomic status
• Lack of breastfeeding (breast milk contains IgA, lysozyme)

---

2. Causative Organisms

Note: After introduction of conjugated pneumococcal vaccine (PCV-7, PCV-13), S. pneumoniae incidence has shifted to non-vaccine serotypes; H. influenzae is now the predominant pathogen in many vaccinated populations — Cummings Otolaryngology, 6e

---

3. Pathogenesis

FLOWCHART: PATHOGENESIS OF ASOM
─────────────────────────────────────────────────────────
  VIRAL URTI / ALLERGIC RHINITIS / NASAL INFECTION
              ↓
  Mucosal inflammation of nasopharynx & ET orifice
              ↓
  Eustachian Tube Dysfunction (ETD)
  ├─ Obstruction (mucosal edema, adenoids)
  ├─ Impaired mucociliary clearance
  └─ Altered pressure equalization
              ↓
  Negative middle ear pressure (Stage 1: Tubal occlusion)
              ↓
  Transudation of fluid into middle ear
              ↓
  Bacterial ascent from nasopharynx via ET
  (by suction effect / active migration)
              ↓
  Bacterial proliferation in middle ear
              ↓
  Mucosal hyperemia & edema → Exudation → Pus formation
              ↓
  Increased middle ear pressure
              ↓
  Tympanic membrane perforation → Discharge → Resolution
─────────────────────────────────────────────────────────

• In children: short (17–18 mm vs. 35–38 mm in adults), horizontal, flaccid, with immature cartilage — allows easier bacterial entry
• Normal ET functions: pressure equalization, mucociliary clearance, protection from nasopharyngeal secretions
• ET dysfunction is the sine qua non of ASOM pathogenesis

• S. pneumoniae: polysaccharide capsule (anti-phagocytic), pneumolysin (damages ciliated epithelium), neuraminidase
• H. influenzae: endotoxin, IgA protease, biofilm formation
• Biofilm formation: A key mechanism of recurrent/persistent OM — bacteria in biofilm are 1000× more resistant to antibiotics

---

CLINICOPATHOLOGICAL STAGES

DIAGRAM: CLINICOPATHOLOGICAL STAGES OF ASOM

   STAGE 1          STAGE 2         STAGE 3
Tubal Occlusion → Hyperemia    → Pre-suppuration
                 (Congestion)

   STAGE 4          STAGE 5
Suppuration    → Resolution / Complications

---

STAGE 1 — STAGE OF TUBAL OCCLUSION (Eustachian Tube Block)

• ET becomes blocked due to nasopharyngeal infection/allergy
• Oxygen in middle ear gets absorbed → negative pressure develops
• Mucosal edema of ET and middle ear
• Mild transudation (serous fluid) begins

• Mild sense of fullness in the ear
• Mild conductive hearing loss
• No pain or fever
• Tympanic membrane: retracted, with handle of malleus prominent and horizontal; cone of light distorted

---

STAGE 2 — STAGE OF HYPEREMIA (Pre-inflammation)

• Marked vascular dilation of TM and middle ear mucosa
• Hyperemia of TM — blood vessels engorged
• Beginning of mucosal edema
• Infiltration by polymorphonuclear leucocytes (PMNs)

• Earache begins (otalgia)
• Low-grade fever
• Conductive hearing loss
• Tinnitus

• TM: red/hyperemic along the handle of malleus initially
• Vessels radiate outward from handle (spoke-wheel pattern)
• TM begins to lose translucency

---

STAGE 3 — STAGE OF EXUDATION / PRE-SUPPURATION

• Marked exudation into middle ear cleft
• Middle ear fills with seropurulent/purulent exudate
• Marked mucosal thickening with goblet cell proliferation
• PMN, macrophage, and lymphocyte infiltration
• TM bulges outward due to pressure build-up

• Severe, throbbing, pulsatile otalgia (worst stage for pain)
• High fever (up to 39–40°C), constitutional symptoms
• Significant conductive hearing loss
• Tinnitus, feeling of fullness
• Child may be irritable, pull at ear

• TM: bright red, opaque, tense, bulging (especially in posterosuperior quadrant)
• Cone of light absent
• All landmarks obscured
• TM bulges outward — "red cherry" appearance

---

STAGE 4 — STAGE OF SUPPURATION (Perforation)

• Continued pus accumulation → ischemic necrosis of TM
• Spontaneous perforation of TM (usually anteroinferior quadrant, small, central)
• Pus drains into EAC
• Pressure in middle ear relieved

• Sudden RELIEF of pain (pathognomonic)
• Fever decreases
• Mucopurulent/purulent otorrhoea begins
• Patient feels better subjectively
• Hearing may temporarily worsen then improve as drainage begins

• Pulsatile purulent discharge in EAC ("lighthouse sign" — pulsatile streaming)
• Small central perforation (pinhole) in TM with surrounding hyperemia
• After cleaning: TM appears red with perforation

---

STAGE 5 — STAGE OF RESOLUTION (or Complications)

• Discharge subsides over 1–2 weeks
• TM perforation heals spontaneously
• Middle ear returns to normal
• Hearing restored
• Pathology: re-epithelialization of perforation, resolution of mucosal edema

FLOWCHART: OUTCOME OF ASOM

                    ASOM
                      │
          ┌───────────┴───────────┐
       Resolution (80%)    No Resolution (20%)
          │                       │
     Complete recovery    ┌───────┴────────┐
                       OM with effusion  Complications
                          (Glue ear)          │
                                    ┌─────────┴──────────┐
                               Extracranial         Intracranial
                               ─────────────         ─────────────
                               • Mastoiditis         • Meningitis
                               • Facial palsy        • Brain abscess
                               • Labyrinthitis       • Lateral sinus
                               • Petrositis            thrombosis
                               • Subperiosteal       • Extradural
                                 abscess               abscess
                                                     • Subdural
                                                       abscess
                                                     • Otitic
                                                       hydrocephalus

---

CLINICAL FEATURES (Summary)

1. Otalgia — deep, throbbing, constant; worst in suppurative stage; relieved on perforation
2. Otorrhoea — purulent discharge after spontaneous perforation
3. Hearing loss — conductive (20–30 dB)
4. Fever — high-grade, especially in children
5. Tinnitus
6. Deafness — temporary conductive hearing loss

• Tenderness over tragus (tragal sign — positive in children)
• Tenderness over mastoid (in case of mastoid involvement)
• Otoscopic findings (stage-dependent, described above)

• Irritability, crying, pulling at ear
• Feeding disturbances
• Fever, diarrhea, vomiting

---

DIAGNOSIS

Clinical Diagnosis (AAO-HNS / AAP Criteria for AOM):

1. Acute onset of symptoms
2. Presence of middle ear effusion (bulging TM, air-fluid level, decreased TM mobility on pneumatic otoscopy)
3. Signs/symptoms of middle ear inflammation (erythema, otalgia)

Investigations:

---

MANAGEMENT

FLOWCHART: MANAGEMENT OF ASOM

PATIENT WITH SUSPECTED ASOM
            │
    History + Otoscopy
            │
    Confirm diagnosis
            │
   ┌────────┴─────────┐
Age <2 years       Age ≥2 years
Severe symptoms    Mild-moderate symptoms
            │               │
   ANTIBIOTICS         OBSERVE 48-72 hrs
   IMMEDIATELY         (Watchful Waiting)
                            │
                    No improvement?
                            │
                       ANTIBIOTICS

---

1. WATCHFUL WAITING (Observation Option)

• Age ≥ 2 years
• Unilateral AOM
• Mild symptoms (pain < 48 h, temperature < 39°C)
• Reliable caregiver with access to follow-up
• No prior complications

---

2. ANALGESICS / ANTIPYRETICS

• Paracetamol (15 mg/kg q4–6h) or Ibuprofen — first-line for pain and fever
• Topical analgesic ear drops (benzocaine, antipyrine) — short-term adjunct
• NO codeine in children < 12 years (FDA warning)

---

3. ANTIBIOTIC THERAPY

• Amoxicillin 80–90 mg/kg/day in 2–3 divided doses × 10 days (children <2 years), 5–7 days (≥2 years, mild disease)

• Achieves middle ear fluid concentrations above MIC for resistant S. pneumoniae

---

4. DECONGESTANTS / TOPICAL NASAL DROPS

• Xylometazoline / oxymetazoline nasal drops — reduce mucosal edema, improve ET function
• Evidence: Limited; AAP does NOT recommend antihistamines or decongestants routinely (no proven benefit, side effects in children)

---

5. MYRINGOTOMY (Paracentesis)

• Severe bulging TM with excruciating pain not relieved by analgesics
• TM about to rupture / imminent perforation
• Complications (mastoiditis, meningitis, labyrinthitis)
• Inadequate response to antibiotics
• Immunocompromised patient
• Neonates and young infants
• To obtain material for culture (tympanocentesis)

• Performed under local/general anesthesia
• Incision in anteroinferior quadrant of TM (Schwartze incision)
• Relieves pain immediately
• Allows drainage and culture

---

6. MANAGEMENT AT EACH STAGE

---

7. SURGICAL MANAGEMENT

• Indicated for recurrent AOM (≥3 episodes in 6 months or ≥4 in 1 year) with residual middle ear effusion
• Grommet (ventilation tube) equalizes middle ear pressure, prevents fluid accumulation
• Adenoidectomy may be added if significant adenoid hypertrophy

• Reduces nasopharyngeal bacterial reservoir
• Improves ET function
• Indicated in children > 4 years with recurrent AOM + adenoid hypertrophy

---

COMPLICATIONS

Extracranial Complications:

1. Acute Mastoiditis — most common; pain, tenderness, postauricular swelling, displaced pinna
2. Petrositis (Gradenigo's syndrome) — triad of otorrhoea + deep retro-orbital pain (V nerve) + ipsilateral abducens palsy (VI nerve)
3. Labyrinthitis — serous (reversible) or suppurative (irreversible); vertigo, SNHL
4. Facial Nerve Palsy — due to bony dehiscence of facial canal
5. Subperiosteal Abscess — fluctuant postauricular swelling
6. Bezold Abscess — pus tracks along sternomastoid muscle (tip of mastoid)

Intracranial Complications (per Cummings):

• Meningitis (most common intracranial complication)
• Extradural abscess
• Subdural abscess/empyema
• Brain abscess (temporal lobe, cerebellum)
• Lateral (sigmoid) sinus thrombophlebitis — picket-fence fever, Griesinger's sign
• Otitic hydrocephalus

---

RECENT ADVANCES (2015–2024)

1. Pneumococcal Vaccination

• PCV-7 (2000), PCV-13 (2010): Significant reduction in AOM due to vaccine serotypes
• PCV-13 reduced AOM-related doctor visits by ~50%
• Serotype replacement by non-vaccine strains (especially 19A) is an ongoing challenge

2. Biofilm Research

• S. pneumoniae, H. influenzae, and M. catarrhalis form polymicrobial biofilms on middle ear mucosa
• Biofilms are 100–1000× more resistant to antibiotics — explains recurrent/chronic OM
• Emerging strategies: N-acetylcysteine (biofilm disruption), D-amino acids, phage therapy

3. Genetic Susceptibility

• Twin studies: 70–80% heritability for recurrent AOM
• Genetic variants in TLR signaling (TLR4, TLR9), mucin genes (MUC5B), and complement genes implicated
• Pharmacogenomics may guide future individualized therapy

4. Viral-Bacterial Interaction

• RSV, rhinovirus, influenza enhance S. pneumoniae adherence by upregulating platelet-activating factor receptor (PAFR) on epithelium
• Influenza vaccination reduces AOM incidence by 30–40% in children

5. Endoscopic Ear Surgery

• High-definition endoscopy improves visualization of middle ear during myringotomy
• Better outcomes in identifying effusion loculations

6. Probiotics

• Lactobacillus rhamnosus, Streptococcus salivarius K12 — reduce AOM recurrence in some RCTs
• Nasal Streptococcus salivarius colonization reduces pathogenic bacteria in nasopharynx

7. Updated Antibiotic Guidelines (AAP 2022)

• Confirmed severe AOM (bilateral or with otorrhoea) in children < 2 years: immediate antibiotics
• Observation period extended up to 72 hours for mild unilateral AOM in older children
• Shared decision-making with "safety net" antibiotic prescriptions

8. Tympanostomy Tube Advances

• Silverstein MicroWick: drug delivery to middle ear
• Bioabsorbable tubes (e.g., BVAC tubes): self-dissolving, no second procedure needed
• Drug-eluting tubes: impregnated with antibiotics/anti-biofilm agents

---

DIFFERENTIAL DIAGNOSIS

---

PREVENTION

1. Pneumococcal vaccine (PCV-13) and influenza vaccine
2. Exclusive breastfeeding for 6 months
3. Avoid supine bottle-feeding
4. Reduce passive smoke exposure
5. Limit daycare attendance in high-risk children
6. Nasal saline irrigation in recurrent upper respiratory infections
7. Prophylactic antibiotics (amoxicillin 20 mg/kg at bedtime) — limited role; not routinely recommended due to resistance

---

SUMMARY TABLE

---

KEY REFERENCES

• Cummings Otolaryngology Head and Neck Surgery, 6e — Chapters 131, 141 (Otitis Media, Complications of AOM/COM)
• K.J. Lee's Essential Otolaryngology, 11e
• Scott-Brown's Otolaryngology, Head and Neck Surgery, 8e — Vol. 3
• Stell & Maran's Head and Neck Surgery, 5e
• Dhingra P.L. — Diseases of Ear, Nose & Throat, 7e (Stages of ASOM, management)
• Hazarika P. — Textbook of ENT & Head Neck Surgery
• Zakir Hussain — ENT Short Cases
• AAP Clinical Practice Guideline: Otitis Media (2013, updated 2022)
• Red Book 2021 — Otitis Media section
• Lieberthal AS et al. — The diagnosis and management of AOM. Pediatrics 2013;131:e964
• Kaur R et al. — Trends in acute otitis media bacteriology. Pediatr Infect Dis J, 2016

---

Note on image generation: Diagrams illustrating tympanic membrane changes across the 5 stages, Eustachian tube anatomy in children vs. adults, and tympanogram tracings are standard in Dhingra's and Hazarika's textbooks. The generate_image tool has reached its monthly limit on this account — please upgrade your subscription plan to generate visual diagrams. The flowcharts above represent the key pathways in text format.

---

• Etiopathogenesis with flowchart
• 5 clinicopathological stages with otoscopic findings
• Management at each stage with drug doses and flowcharts
• Complications (extra- and intracranial)
• Recent advances (vaccines, biofilm, genetics, new surgical techniques)
• Multi-textbook referencing per RGUHS standard